MEDICAL PRODUCTS
Human Ultracell V IM
Human Ultracell V Oral
Human Citoplacell 3G
Revercell 3G
Cellorgane Multi-Complex 3G
Androcell 3G
Biofemin 3G
Bioenzym 3G
Celltox 3G
Mekenz H7 3G
Cellorgane Man
Cellorgane Woman
Formula 1 Skin & Muscle
Formula 2 Liver
Formula 3 Heart-Artery-Vein
Formula 4 Bone-Cartilage
Formula 5 Kidney - Nephrons
Formula 6 Lungs
Formula 7 Brain-Hypothalamus-Pituitary
Formula 8 Adrenal Gland
Formula 9 Thymus - Spleen
Formula 10 Pancreas
Formula 11 Esophagus-Stomach-Intestines
Formula 12 Thyroid
LOGGED IN
No one logged in.

Cellorgane® Multi-Complex 3G Formula 7 Brain - Hypothalamus - Pituitary

Central Nervous System

Problem

With age, organ function progressively decreases due to cell deterioration, caused mainly by oxidative stress; this generates vitality and quality of life losses.
This organic sub function predisposes to chronic degenerative diseases.
Damage by oxidative stress, chronic diseases, neurological cognitive deficiencies.

Uses

Migraine, Headache, Neuralgia, Sciatica, Depressive States, Acute and Chronic Stress, Diabetes Mellitus type II, lack of concentration and memory, Alzheimer and Parkinson initial stages, Attention Deficit Disorder (ADD) in adult patients and Aging.

Solution

The contribution of cellular cytokines and growth factors in embryonic extracts has a refreshing and revitalizing effect at the cellular level, which increases the specific functionality of the organ to be treated.
Antioxidant enzymes neutralize free radicals, thereby reducing damage from oxidative stress.

Composition

Oral CELLORGANE 7 Each 500-mg enteric coated tablet contains: Opotherapic cell extracts: Brain 15%, Hypothalamus 15%, Pituitary 15%, 10% formulated Enzyme Therapy 10%, embryonic ectoderm 10%, Thymus 10%, Placenta 10%; Glutamic Acid 2%, Phosphatidylserine 1%, Zymocell complex enzyme, superoxide dismutase, glutathione peroxidase, glutathione reductase, glutathione transferase; stabilizers and Maltodextrin 11%.

Injectable CELLORGANE 7
Each 750-mg Lyophilized Vial contains:
Opotherapic cell extracts: Brain 15%, 15% Hypothalamus, Pituitary 15%, enzyme therapy
Zymocell 15%, 10% embryonic endoderm, Thymus 10%, mannitol 20% and stabilizers.

Each 10-ml/250-mg Solvent Vial contains:
Opotherapic cell extracts Placenta 10%, procaine 2%, Sodium chloride 0.9%; Enzyme complex: Superoxide dismutase, glutathione peroxidase, glutathione reductase, glutathione transferase, stabilizers and sufficient sterilized Water for injection.

Action Mechanisms

Formula components reach the cells directly or indirectly, in the case of oral products, by bloodstream, and are selectively incorporated into the cells through various means of cellular transport.
It acts revitalizing the nervous system at the cellular level, improving its functionality and reducing the risk of degenerative diseases

Contraindications

  • Allergies to animal proteins.
  • Allergy to any of its components.
  • Pregnancy and lactation.

Posology

Neuralgia, Diabetes Mellitus type II, Alzheimer's, Parkinson's and Sciatica

Orally: Two tablets in the morning and 2 at night, for at least six months.

Intramuscular:
2 ml daily for 5 days, rest for two days and restart with 2 ml daily for 5 days. Repeat treatment at 6 months.

Migraine, Headache, Neuralgia, Depressive States, Acute and Chronic Stress, lack of concentration and memory, Attention Deficit Disorder (DDA) in adult patients

Orally: Two tablets in the morning and 2 at night, for at least three months.
The tablets are taken in the morning on an empty stomach and at night before dinner (30 minutes before meals).

Intramuscular:
2 ml daily for 5 days. Repeat treatment at 6 months.

Note: The dose may be increased according to the clinical picture of the patient and the physician's discretion; the results depend on the completion of treatment.

Adjuvant treatment with:

Antihypertensive and heart failure
  • Calcium antagonists: Nifedipine
  • ACE inhibitors: Enalapril, Captopril
  • ARB-II: losartan, candesartan
  • Beta-blockers: Atenolol, Metoprolol, Carvedilol, Bisoprolol
  • Thiazide diuretics: Hydrochlorothiazide, chlorthalidone, indapamide, xipamide, Ameride (thiazide & K+ saver)
Hypoglycemic
  • Biguanides: Metformin
  • Inhibitors of alpha-glucosidase: Acarbose
  • Sulfonylureas: glibenclamide, glimepiride, glyburide and Tolazamide
  • Injectable drugs (like GLP-1): Sitagliptin, Saxagliptin, and linagliptin
  • Meglitinides: Repaglinide, nateglinide
  • SGLT2 Inhibitors: Dapagliflozin
  • Thiazolidinediones: Pioglitazone
  • DPP IV inhibitors: Sitagliptin and vildagliptin
  • Injectable insulin
Diuretics
  • Loop diuretics: Furosemide, Amiloride
  • Thiazide and analogues: IDEM (above)
  • K + Savers: Spironolactone
  • Osmotic: Mannitol
Statins

Selective, competitive inhibitors of HMG-CoA reductase: atorvastatin, simvastatin, pravastatin

Coronary vasodilators
  • Antianginal: Calcium antagonists - Nifedipine
  • Competitive antagonist of beta 1 and beta 2 adrenergic receptors: Propranolol
Heart failure Digitalis: Digoxin
Venous insufficiency
  • Venotonic and vasculoprotective drugs: Diosmin, Hidrosmin, Horse Chestnut Seed
Alzheimer
  • Reversible inhibitor of the enzyme acetylcholinesterase: Donepezil, Galantamine
  • NMDA receptor antagonist: Memantine
  • Neurometabolic stimulator: Piracetam
  • Porcine-brain derived peptide preparation: Cerebrolysin
  • Cholinesterase inhibitors: Rivastigmine
Hormone Replacement Therapy Estrogen, Progesterone, Testosterone, Prasterone, Mesterolone, Fluoxymesterone
Chemotherapy
  • Methotrexate, actinomycin D, vincristine, ifosfamide, Raltitrexed, Bevacizumab, Irinotecan, oxaliplatin, cetuximab, capecitabine, carboplatin, tamoxifen, cisplatin, Megestrol
  • Gestonorone, Anastrozole, Paclitaxel, Vinorelbine, Trastuzumab, leuprorelin, Diethylstilbestrol, Nilutamide, epirubicin, among others
Antidepressants
  • Selective serotonin reuptake inhibitors (SSRI): paroxetine, sertraline, fluoxetine, citalopram, escitalopram
  • Serotonin–norepinephrine reuptake inhibitors (SNRIs): venlafaxine, duloxetine, Desvenlafaxine
  • NaSSA: Mirtazapine
  • Tricyclic: amitriptyline, clomipramine, imipramine
  • MAOIs: Moclobemide
  • Serotonin–norepinephrine reuptake inhibitor (SNRI): Reboxetine
  • Dopamine-norepinephrine reuptake inhibitor (DNRI): Bupropion
Anti-anemic Iron
Renal impairment Recombinant erythropoietin, Furosemide, Amino Acids
Erectile dysfunction (ED) cyclic GMP-specific phosphodiesterase type 5 (PDE5): Sildenafil

Who We Are

Biocell Ultravital™ researches and develops innovative, 100% natural, pharmaceutical-grade bioproducts, on an exclusive basis worldwide. These products optimise cell nutrition and energy, producing a preventative and curative action which, in addition to treating pre-symptoms and symptoms by means of cell renewal, refuels and corrects the cell structure of tissues and organs, preventing the appearance of the functional stress loads which give rise to poor cell formation, degenerative diseases, and their after-effects.

Policies

Product developed under pharmaceutical control according to European CE standards. Made in the EC by Biocell Laboratory France, licensed and authorized by Biocell Ultravital GmbH, Switzerland.

Privacy

This website is governed by applicable laws and government regulations. Please see our Privacy Policy.
Use of this site constitutes your consent to application of such laws and regulations.

© 2019 Biocell Ultravital